A
OLMA icon

AlphaQuest’s Olema Pharmaceuticals OLMA Stock Holding History

AlphaQuest’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,690
Closed -$42.3K – 1418
2025
Q4 		$42.3K Buy
1,690
+792
+88% +$14.1K ﹤0.01% 1980
2025
Q3 		$8.79K Hold
898
– – ﹤0.01% 2173
2025
Q2 		$3.83K Hold
898
– – ﹤0.01% 1901
2025
Q1 		$3.38K Sell
898
-17,516
-95% -$88.1K ﹤0.01% 1882
2024
Q4 		$107K Buy
18,414
+16,511
+868% +$165K 0.01% 1070
2024
Q3 		$22.7K Buy
+1,903
New +$24.3K ﹤0.01% 1498
2024
Q2 		– Sell
-8,215
Closed -$93K – 1801
2024
Q1 		$93K Buy
+8,215
New +$106K 0.02% 830

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

AlphaQuest's OLMA Position: Q1 2026 in Review

AlphaQuest sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 1,690 shares — an estimated $42.3K sold.

AlphaQuest first reported a position in OLMA in Q1 2024 and held it in 7 quarters. The position peaked at $107K in Q4 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • AlphaQuest reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,690 Olema Pharmaceuticals shares in Q1 2026, an estimated $42.3K.
  • AlphaQuest first reported a position in Olema Pharmaceuticals in Q1 2024 and held it in 7 quarters.
  • AlphaQuest's Olema Pharmaceuticals position peaked at $107K in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.